• Sleep Disturbance Among Patients With Psoriasis and Atopy and Comparison Between Them
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Sleep Disturbance
- Sponsor
- Assiut University
- Enrollment
- 150
- Primary Endpoint
- severity of the psooriasis (Psoriasis Area and Severity Index)
- Last Updated
- 7 years ago
Overview
Brief Summary
Comparison between sleep disturbance in atopy and psoriasis and control
Detailed Description
Sleep is essential for daytime functioning and health and important for both psychological and physiological wellbeing . A growing body of research indicates that chronic sleep disturbance is associated with impaired quality of life (QoL) and a risk factor for poorer health, for example depression cardiovascular disease, hypertension 1 and diabetes. insomnia, the most common sleep disorder, is a clinical condition defined as difficulties falling asleep and/or maintaining sleep and/or poor sleep quality despite adequate opportunity for sleep resulting in significant daytime impairment. The development of insomnia in healthy populations has a bi-directional relationship with psychological factors such as anxiety, depressive symptoms and stress, and may in clinical populations also be associated with physical symptoms, such as pain. the physical symptoms in psoriasis, such as itch, one would expect a higher prevalence of sleep disturbance in this patient group. On the other hand Sleep disturbance is common also in patients with atopic dermatitis (AD). Patients with AD often have sleep disturbances due to pruritus.
Investigators
Amani Mahmoud Abdelmohsen
Principal Investigator
Assiut University
Eligibility Criteria
Inclusion Criteria
- •patients with Psoriasis and Patients with A topic dermatitis
Exclusion Criteria
- •All patient have another dermatological disease
Outcomes
Primary Outcomes
severity of the psooriasis (Psoriasis Area and Severity Index)
Time Frame: 1 hour
calculation of the severity through questionaire , 0 = None 1. = Slight 2. = Moderate 3. = Severe 4. = Very severe
Secondary Outcomes
- 2.HRQoL (Dermatology Life Quality Index);(1 hour)
- .insomnia severity [Insomnia Severity Index (ISI)];(1 hour)
- sleep quality [Pittsburgh Sleep Quality Index (PSQI)];(1 hour)
- stress (Perceived Stress Scale);(1 hour)
- itch (Itch Severity Scale);(1 hour)
- and depressive symptoms (Beck Depression Inventory(1 hour)
- severity of a topic dermatitis(1 hour)